Literature DB >> 10862783

Immune recognition of OxLDL in atherosclerosis.

J F Kearney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10862783      PMCID： PMC378521          DOI： 10.1172/JCI10426

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  23 in total

1.  Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice.

Authors:  C L Benedict; J F Kearney
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

2.  Control of early viral and bacterial distribution and disease by natural antibodies.

Authors:  A F Ochsenbein; T Fehr; C Lutz; M Suter; F Brombacher; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

3.  A receptor for phosphatidylserine-specific clearance of apoptotic cells.

Authors:  V A Fadok; D L Bratton; D M Rose; A Pearson; R A Ezekewitz; P M Henson
Journal:  Nature       Date:  2000-05-04       Impact factor: 49.962

4.  All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes.

Authors:  H Masmoudi; T Mota-Santos; F Huetz; A Coutinho; P A Cazenave
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

Review 5.  Idiotypic regulation of development of the B-cell repertoire.

Authors:  M Elliott; J F Kearney
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

6.  Studies on phosphorylcholine-specific T cell idiotypes and idiotype-specific immunity.

Authors:  R Benca; J Quintáns; J F Kearney; P M Flood; H Schreiber
Journal:  Mol Immunol       Date:  1980-07       Impact factor: 4.407

7.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

Authors:  P X Shaw; S Hörkkö; M K Chang; L K Curtiss; W Palinski; G J Silverman; J L Witztum
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice.

Authors:  J F Kearney; R Barletta; Z S Quan; J Quintáns
Journal:  Eur J Immunol       Date:  1981-11       Impact factor: 5.532

9.  Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.

Authors:  L S McDaniel; W H Benjamin; C Forman; D E Briles
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

10.  Antigen-independent selection of T15 idiotype during B-cell ontogeny in mice.

Authors:  M Vakil; D E Briles; J F Kearney
Journal:  Dev Immunol       Date:  1991
View more
  14 in total

1.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 2.  Innate and adaptive immune response to apoptotic cells.

Authors:  Yufeng Peng; David A Martin; Justin Kenkel; Kang Zhang; Carol Anne Ogden; Keith B Elkon
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

Review 3.  B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.

Authors:  Daniel A Winer; Shawn Winer; Melissa H Y Chng; Lei Shen; Edgar G Engleman
Journal:  Cell Mol Life Sci       Date:  2013-10-15       Impact factor: 9.261

4.  Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease.

Authors:  Christian A Gleissner; Christian Erbel; Julia Haeussler; Mohammadreza Akhavanpoor; Gabriele Domschke; Fabian Linden; Andreas O Doesch; Göran Conradson; Sebastian J Buss; Nina P Hofmann; Gitsios Gitsioudis; Hugo A Katus; Grigorios Korosoglou
Journal:  Clin Res Cardiol       Date:  2014-08-08       Impact factor: 5.460

Review 5.  Adaptive immunity and adipose tissue biology.

Authors:  Denise A Kaminski; Troy D Randall
Journal:  Trends Immunol       Date:  2010-10       Impact factor: 16.687

6.  Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.

Authors:  H A Schenkein; C R Berry; D Purkall; J A Burmeister; C N Brooks; J G Tew
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 7.  Natural antibodies and the autoimmunity of atherosclerosis.

Authors:  Christoph J Binder; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

8.  Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Authors:  Daiju Ichikawa; Masanao Asano; Susan A Shinton; Joni Brill-Dashoff; Anthony M Formica; Anna Velcich; Richard R Hardy; Kyoko Hayakawa
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

9.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

10.  Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.

Authors:  Meng-Yun Chou; Linda Fogelstrand; Karsten Hartvigsen; Lotte F Hansen; Douglas Woelkers; Peter X Shaw; Jeomil Choi; Thomas Perkmann; Fredrik Bäckhed; Yury I Miller; Sohvi Hörkkö; Maripat Corr; Joseph L Witztum; Christoph J Binder
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.